{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:15:55Z","timestamp":1783473355037,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"DOI":"10.1007\/s00253-026-13852-8","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:54:56Z","timestamp":1778759696000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Human anti-alpha-hemolysin scFvs mitigate toxin-mediated damage in a mouse model of MRSA pneumonia"],"prefix":"10.1007","volume":"110","author":[{"given":"Somayeh","family":"Piri-Gavgani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid Reza","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzaneh","family":"Nazari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abolfazl","family":"Fateh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Davar","family":"Siadat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Rahimi-Jamnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"key":"13852_CR1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.omto.2019.02.004","volume":"14","author":"R Ahamadi-Fesharaki","year":"2019","unstructured":"Ahamadi-Fesharaki R, Fateh A, Vaziri F, Solgi G, Siadat SD, Mahboudi F, Rahimi-Jamnani F (2019) Single-chain variable fragment-based bispecific antibodies: hitting two targets with one sophisticated arrow. Mol Ther Oncol 14:38","journal-title":"Mol Ther Oncol"},{"issue":"9","key":"13852_CR2","first-page":"1141","volume":"25","author":"E Basardeh","year":"2022","unstructured":"Basardeh E, Piri-Gavgani S, Soltanmohammadi B, Ghanei M, Omrani MD, Soezi M, Shokrgozar MA, Azizi M, Fateh A, Vaziri F (2022) Anti-Acinetobacter baumannii single-chain variable fragments show direct bactericidal activity. Iran J Basic Med Sci 25(9):1141\u20131149","journal-title":"Iran J Basic Med Sci"},{"issue":"1","key":"13852_CR3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12866-023-03080-9","volume":"24","author":"E Basardeh","year":"2024","unstructured":"Basardeh E, Piri-Gavgani S, Moradi HR, Azizi M, Mirzabeigi P, Nazari F, Ghanei M, Mahboudi F, Rahimi-Jamnani F (2024) Anti-Acinetobacter baumannii single-chain variable fragments provide therapeutic efficacy in an immunocompromised mouse pneumonia model. BMC Microbiol 24(1):55","journal-title":"BMC Microbiol"},{"issue":"8","key":"13852_CR4","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1128\/IAI.00089-14","volume":"82","author":"BJ Berube","year":"2014","unstructured":"Berube BJ, Sampedro GR, Otto M, Wardenburg JB (2014) The psm\u03b1 locus regulates production of Staphylococcus aureus alpha-toxin during infection. Infect Immun 82(8):3350\u20133358","journal-title":"Infect Immun"},{"issue":"1","key":"13852_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/1472-6750-11-113","volume":"11","author":"S Chahboun","year":"2011","unstructured":"Chahboun S, Hust M, Liu Y, Pelat T, Miethe S, Helmsing S, Jones RG, Sesardic D, Thullier P (2011) Isolation of a nanomolar scFv inhibiting the endopeptidase activity of Botulinum Toxin A, by single-round panning of an immune phage-displayed library of macaque origin. BMC Biotechnol 11(1):113","journal-title":"BMC Biotechnol"},{"key":"13852_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12010117","author":"BC Chan","year":"2023","unstructured":"Chan BC, Barua N, Lau CB, Leung PC, Fung KP, Ip M (2023) Enhancing antibiotics efficacy by combination of kuraridin and epicatechin gallate with antimicrobials against methicillin-resistant Staphylococcus aureus. Antibiotics (Basel). https:\/\/doi.org\/10.3390\/antibiotics12010117","journal-title":"Antibiotics (Basel)"},{"key":"13852_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.125608","volume":"246","author":"G Chang","year":"2023","unstructured":"Chang G, Luo Z, Zhang Y, Xu X, Zhou T, Chen D, Li L, Wang X (2023) Electron beam irradiation degrades the toxicity and alters the protein structure of Staphylococcus aureus alpha-hemolysin. Int J Biol Macromol 246:125608","journal-title":"Int J Biol Macromol"},{"issue":"6","key":"13852_CR8","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1093\/infdis\/jiy597","volume":"219","author":"X Chen","year":"2019","unstructured":"Chen X, Sun Y, Missiakas D, Schneewind O (2019) Staphylococcus aureus decolonization of mice with monoclonal antibody neutralizing protein a. J Infect Dis 219(6):884\u2013888","journal-title":"J Infect Dis"},{"issue":"329","key":"13852_CR9","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aad9922","volume":"8","author":"TS Cohen","year":"2016","unstructured":"Cohen TS, Hilliard JJ, Jones-Nelson O, Keller AE, O\u2019day T, Tkaczyk C, DiGiandomenico A, Hamilton M, Pelletier M, Wang Q (2016) Staphylococcus aureus \u03b1 toxin potentiates opportunistic bacterial lung infections. Sci Transl Med 8(329):329ra31","journal-title":"Sci Transl Med"},{"key":"13852_CR10","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02456-16","author":"BA Diep","year":"2017","unstructured":"Diep BA, Hilliard JJ, Le VT, Tkaczyk C, Le HN, Tran VG, Rao RL, Dip EC, Pereira-Franchi EP, Cha P, Jacobson S, Broome R, Cheng LI, Weiss W, Prokai L, Nguyen V, Stover CK, Sellman BR (2017) Targeting alpha toxin to mitigate its lethal toxicity in ferret and rabbit models of Staphylococcus aureus necrotizing pneumonia. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.02456-16","journal-title":"Antimicrob Agents Chemother"},{"key":"13852_CR11","doi-asserted-by":"crossref","unstructured":"Ferraz M (2024) Antimicrobial resistance: the impact from and on society according to one health approach. Societies 14(9):187","DOI":"10.3390\/soc14090187"},{"issue":"10","key":"13852_CR12","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/j.jmb.2013.02.008","volume":"425","author":"D Foletti","year":"2013","unstructured":"Foletti D, Strop P, Shaughnessy L, Hasa-Moreno A, Casas MG, Russell M, Bee C, Wu S, Pham A, Zeng Z (2013) Mechanism of action and in vivo efficacy of a human-derived antibody against Staphylococcus aureus \u03b1-hemolysin. J Mol Biol 425(10):1641\u20131654","journal-title":"J Mol Biol"},{"issue":"11","key":"13852_CR13","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1007\/s00134-018-5229-2","volume":"44","author":"B Fran\u00e7ois","year":"2018","unstructured":"Fran\u00e7ois B, Mercier E, Gonzalez C, Asehnoune K, Nseir S, Fiancette M, Desachy A, Plantef\u00e8ve G, Meziani F, De Lame P-A (2018) Safety and tolerability of a single administration of AR-301, a human monoclonal antibody, in ICU patients with severe pneumonia caused by Staphylococcus aureus: first-in-human trial. Intensive Care Med 44(11):1787\u20131796","journal-title":"Intensive Care Med"},{"issue":"9","key":"13852_CR14","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/S1473-3099(20)30995-6","volume":"21","author":"B Fran\u00e7ois","year":"2021","unstructured":"Fran\u00e7ois B, Jafri HS, Chastre J, S\u00e1nchez-Garc\u00eda M, Eggimann P, Dequin P-F, Huberlant V, Soria LV, Boulain T, Bretonni\u00e8re C (2021) Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial. Lancet Infect Dis 21(9):1313\u20131323","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"13852_CR15","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1128\/AAC.03918-14","volume":"59","author":"JJ Hilliard","year":"2015","unstructured":"Hilliard JJ, Datta V, Tkaczyk C, Hamilton M, Sadowska A, Jones-Nelson O, O\u2019Day T, Weiss WJ, Szarka S, Nguyen V (2015) Anti-alpha-toxin monoclonal antibody and antibiotic combination therapy improves disease outcome and accelerates healing in a Staphylococcus aureus dermonecrosis model. Antimicrob Agents Chemother 59(1):299\u2013309","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"13852_CR16","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1128\/AAC.02190-13","volume":"58","author":"L Hua","year":"2014","unstructured":"Hua L, Hilliard J, Shi Y, Tkaczyk C, Cheng L, Yu X, Datta V, Ren S, Feng H, Zinsou R (2014) Assessment of an anti-alpha-toxin monoclonal antibody for prevention and treatment of Staphylococcus aureus-induced pneumonia. Antimicrob Agents Chemother 58(2):1108\u20131117","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"13852_CR17","doi-asserted-by":"publisher","first-page":"4526","DOI":"10.1128\/AAC.00510-15","volume":"59","author":"L Hua","year":"2015","unstructured":"Hua L, Cohen T, Shi Y, Datta V, Hilliard J, Tkaczyk C, Suzich J, Stover C, Sellman B (2015) MEDI4893* promotes survival and extends the antibiotic treatment window in a Staphylococcus aureus immunocompromised pneumonia model. Antimicrob Agents Chemother 59(8):4526\u20134532","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"13852_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13111046","volume":"13","author":"S Ke","year":"2024","unstructured":"Ke S, Kil H, Roggy C, Shields T, Quinn Z, Quinn AP, Small JM, Towne FD, Brooks AE, Brooks BD (2024) Potential therapeutic targets for combination antibody therapy against Staphylococcus aureus infections. Antibiotics Basel 13(11):1046","journal-title":"Antibiotics Basel"},{"issue":"3","key":"13852_CR19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.23838\/pfm.2018.00079","volume":"2","author":"KS Lee","year":"2018","unstructured":"Lee KS, Kim TJ, Peck KR, Han J (2018) Infectious pneumonia in immunocompetent patients: updates in clinical and imaging features. Precis Future Med 2(3):79\u201394","journal-title":"Precis Future Med"},{"issue":"3","key":"13852_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120481","volume":"10","author":"D Luz","year":"2015","unstructured":"Luz D, Chen G, Maranhao AQ, Rocha LB, Sidhu S, Piazza RM (2015) Development and characterization of recombinant antibody fragments that recognize and neutralize in vitro Stx2 toxin from Shiga toxin-producing Escherichia coli. PLoS One 10(3):e0120481","journal-title":"PLoS One"},{"issue":"4","key":"13852_CR21","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/1348-0421.12242","volume":"59","author":"H Ohsawa","year":"2015","unstructured":"Ohsawa H, Baba T, Enami J, Hiramatsu K (2015) Successful selection of an infection\u2010protective anti\u2010Staphylococcus aureus monoclonal antibody and its protective activity in murine infection models. Microbiol Immunol 59(4):183\u2013192","journal-title":"Microbiol Immunol"},{"issue":"5","key":"13852_CR22","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/infdis\/jit235","volume":"208","author":"T Parimon","year":"2013","unstructured":"Parimon T, Li Z, Bolz DD, McIndoo ER, Bayer CR, Stevens DL, Bryant AE (2013) Staphylococcus aureus alpha-hemolysin promotes platelet-neutrophil aggregate formation. J Infect Dis 208(5):761\u2013770","journal-title":"J Infect Dis"},{"issue":"8","key":"13852_CR23","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1128\/AAC.01528-06","volume":"51","author":"T Pelat","year":"2007","unstructured":"Pelat T, Hust M, Laffly E, Condemine F, Bottex C, Vidal D, Lefranc M-P, D\u00fcbel S, Thullier P (2007) High-affinity, human antibody-like antibody fragment (single-chain variable fragment) neutralizing the lethal factor (LF) of Bacillus anthracis by inhibiting protective antigen-LF complex formation. Antimicrob Agents Chemother 51(8):2758\u20132764","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"13852_CR24","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1055\/s-0041-1740583","volume":"43","author":"CI Pickens","year":"2022","unstructured":"Pickens CI, Wunderink RG (2022) Methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia\/ventilator-associated pneumonia. Semin Respir Crit Care Med 43(2):304\u2013309","journal-title":"Semin Respir Crit Care Med"},{"issue":"10","key":"13852_CR25","first-page":"1207","volume":"25","author":"S Piri-Gavgani","year":"2022","unstructured":"Piri-Gavgani S, Ghanei M, Fateh A, Siadat SD, Nematollahi L, Rahimi-Jamnani F (2022) Identification of two neutralizing human single-chain variable fragment antibodies targeting Staphylococcus aureus alpha-hemolysin. Iran J Basic Med Sci 25(10):1207\u20131214","journal-title":"Iran J Basic Med Sci"},{"issue":"6","key":"13852_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007112","volume":"14","author":"EJ Pollitt","year":"2018","unstructured":"Pollitt EJ, Szkuta PT, Burns N, Foster SJ (2018) Staphylococcus aureus infection dynamics. PLoS Pathog 14(6):e1007112","journal-title":"PLoS Pathog"},{"issue":"7","key":"13852_CR27","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1128\/IAI.00115-09","volume":"77","author":"BE Ragle","year":"2009","unstructured":"Ragle BE, Wardenburg JB (2009) Anti-alpha-hemolysin monoclonal antibodies mediate protection against Staphylococcusaureus pneumonia. Infect Immun 77(7):2712\u20132718","journal-title":"Infect Immun"},{"issue":"1","key":"13852_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-025-03825-8","volume":"25","author":"F Rahimi-Jamnani","year":"2025","unstructured":"Rahimi-Jamnani F, Moradi HR, Fateh A, Azizi M, Nazari F, Soezi M, Siadat SD (2025) The therapeutic efficacy of MS473, a fully human single-chain variable fragment targeting Staphylococcus aureus Toxic Shock Syndrome Toxin-1, in a D-galactosamine-sensitized mouse model of lethal shock. BMC Microbiol 25(1):95","journal-title":"BMC Microbiol"},{"issue":"2","key":"13852_CR29","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3390\/toxins9020050","volume":"9","author":"T Rukkawattanakul","year":"2017","unstructured":"Rukkawattanakul T, Sookrung N, Seesuay W, Onlamoon N, Diraphat P, Chaicumpa W, Indrawattana N (2017) Human scFvs that counteract bioactivities of Staphylococcusaureus TSST-1. Toxins (Basel) 9(2):50","journal-title":"Toxins (Basel)"},{"issue":"1","key":"13852_CR30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s42826-019-0008-y","volume":"35","author":"S Schuetze","year":"2019","unstructured":"Schuetze S, Manig A, Ribes S, Nau R (2019) Aged mice show an increased mortality after anesthesia with a standard dose of ketamine\/xylazine. Lab Anim Res 35(1):8","journal-title":"Lab Anim Res"},{"issue":"1","key":"13852_CR31","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1128\/JCM.02023-14","volume":"53","author":"BK Sharma-Kuinkel","year":"2015","unstructured":"Sharma-Kuinkel BK, Wu Y, Tabor DE, Mok H, Sellman BR, Jenkins A, Yu L, Jafri HS, Rude TH, Ruffin F (2015) Characterization of alpha-toxin hla gene variants, alpha-toxin expression levels, and levels of antibody to alpha-toxin in hemodialysis and postsurgical patients with Staphylococcus aureus bacteremia. J Clin Microbiol 53(1):227\u2013236","journal-title":"J Clin Microbiol"},{"issue":"4","key":"13852_CR32","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.chom.2025.03.006","volume":"33","author":"A Shekhar","year":"2025","unstructured":"Shekhar A, Di Lucrezia R, Jerye K, Korotkov VS, Harmrolfs K, Rox K, Weich HA, Ghai I, Delhommel F, Becher I (2025) Highly potent quinoxalinediones inhibit \u03b1-hemolysin and ameliorate Staphylococcus aureus lung infections. Cell Host Microbe 33(4):560\u2013572","journal-title":"Cell Host Microbe"},{"issue":"1","key":"13852_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12896-022-00760-8","volume":"22","author":"M Soezi","year":"2022","unstructured":"Soezi M, Piri-Gavgani S, Ghanei M, Omrani MD, Soltanmohammadi B, Bagheri KP, Cohan RA, Vaziri F, Siadat SD, Fateh A, Khatami S, Azizi M, Rahimi-Jamnani F (2022) Identification of a novel fully human anti-Toxic Shock Syndrome Toxin (TSST)-1 single-chain variable fragment antibody averting TSST-1-induced mitogenesis and cytokine secretion. BMC Biotechnol 22(1):31","journal-title":"BMC Biotechnol"},{"issue":"7","key":"13852_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1302","volume":"10","author":"B Soltanmohammadi","year":"2021","unstructured":"Soltanmohammadi B, Piri-Gavgani S, Basardeh E, Ghanei M, Azizi M, Khaksar Z, Sharifzadeh Z, Badmasti F, Soezi M, Fateh A, Azimi P, Siadat SD, Shooraj F, Bouzari S, Omrani MD, Rahimi-Jamnani F (2021) Bactericidal fully human single-chain fragment variable antibodies protect mice against methicillin-resistant Staphylococcusaureus bacteraemia. Clin Transl Immunology 10(7):e1302","journal-title":"Clin Transl Immunology"},{"issue":"1","key":"13852_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-41826-6","volume":"9","author":"L Stulik","year":"2019","unstructured":"Stulik L, Rouha H, Labrousse D, Visram ZC, Badarau A, Maierhofer B, Gro\u00df K, Weber S, Kramari\u0107 MD, Glojnari\u0107 I (2019) Preventing lung pathology and mortality in rabbit Staphylococcus aureus pneumonia models with cytotoxin-neutralizing monoclonal IgGs penetrating the epithelial lining fluid. Sci Rep 9(1):5339","journal-title":"Sci Rep"},{"issue":"2","key":"13852_CR36","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.chom.2018.06.017","volume":"24","author":"BG Surewaard","year":"2018","unstructured":"Surewaard BG, Thanabalasuriar A, Zeng Z, Tkaczyk C, Cohen TS, Bardoel BW, Jorch SK, Deppermann C, Wardenburg JB, Davis RP (2018) \u03b1-Toxin induces platelet aggregation and liver injury during Staphylococcus aureus sepsis. Cell Host Microbe 24(2):271-284. e3","journal-title":"Cell Host Microbe"},{"issue":"12","key":"13852_CR37","first-page":"1983","volume":"218","author":"D Tabor","year":"2018","unstructured":"Tabor D, Oganesyan V, Keller A, Yu L, McLaughlin R, Song E, Warrener P, Rosenthal K, Esser M, Qi Y (2018) Pseudomonas aeruginosa PcrV and Psl, the molecular targets of bispecific antibody MEDI3902, are conserved among diverse global clinical isolates. J Infect Dis 218(12):1983\u20131994","journal-title":"J Infect Dis"},{"issue":"9","key":"13852_CR38","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nrmicro3521","volume":"13","author":"V Thammavongsa","year":"2015","unstructured":"Thammavongsa V, Kim HK, Missiakas D, Schneewind O (2015) Staphylococcal manipulation of host immune responses. Nat Rev Microbiol 13(9):529\u2013543","journal-title":"Nat Rev Microbiol"},{"key":"13852_CR39","doi-asserted-by":"crossref","unstructured":"Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG Jr (2015) Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev 28(3):603\u2013661","DOI":"10.1128\/CMR.00134-14"},{"issue":"12","key":"13852_CR40","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1038\/nm1207-1405","volume":"13","author":"JB Wardenburg","year":"2007","unstructured":"Wardenburg JB, Bae T, Otto M, DeLeo FR, Schneewind O (2007) Poring over pores: \u03b1-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat Med 13(12):1405\u20131406","journal-title":"Nat Med"},{"issue":"4","key":"13852_CR41","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.ijantimicag.2019.08.012","volume":"54","author":"T Welte","year":"2019","unstructured":"Welte T, Kantecki M, Stone GG, Hammond J (2019) Ceftaroline fosamil as a potential treatment option for Staphylococcus aureus community-acquired pneumonia in adults. Int J Antimicrob Agents 54(4):410\u2013422","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"13852_CR42","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/s41598-019-57103-5","volume":"10","author":"EV Wenzel","year":"2020","unstructured":"Wenzel EV, Bosnak M, Tierney R, Schubert M, Brown J, D\u00fcbel S, Efstratiou A, Sesardic D, Stickings P, Hust M (2020) Human antibodies neutralizing diphtheria toxin in vitro and in vivo. Sci Rep 10(1):571","journal-title":"Sci Rep"},{"issue":"1","key":"13852_CR43","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01020-16","volume":"61","author":"X-Q Yu","year":"2017","unstructured":"Yu X-Q, Robbie GJ, Wu Y, Esser MT, Jensen K, Schwartz HI, Bellamy T, Hernandez-Illas M, Jafri HS (2017) Safety, tolerability, and pharmacokinetics of MEDI4893, an investigational, extended-half-life, anti-Staphylococcus aureus alpha-toxin human monoclonal antibody, in healthy adults. Antimicrob Agents Chemother 61(1):10.1128\/aac. 01020-16","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00253-026-13852-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-026-13852-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-026-13852-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:44:56Z","timestamp":1783471496000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00253-026-13852-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13852"],"URL":"https:\/\/doi.org\/10.1007\/s00253-026-13852-8","relation":{},"ISSN":["1432-0614"],"issn-type":[{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]},"assertion":[{"value":"2 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were conducted in accordance with ARRIVE guidelines (\n                      \n                      ) and approved by the Animal Care and Use Committees of the Pasteur Institute of Iran (Ethics No.: IR.PII.REC.1398.031). All methods were performed in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"204"}}